Evidence map›Paper›PMID 31492037›Full record

ArticleMolecules (Basel, Switzerland)2019

In Vivo Anti-Tumor Effects of Citral on 4T1 Breast Cancer Cells via Induction of Apoptosis and Downregulation of Aldehyde Dehydrogenase Activity.

Siyamak Ebrahimi Nigjeh, Swee Keong Yeap, Norshariza Nordin, Heshu Rahman, Rozita Rosli

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Antitumor effects of volatile components ofFrontiers in oncology · 2026
    Article
  4. Review
  5. Article
  6. Role of Phytoconstituents in Cancer Treatment: A Review.Recent advances in food, nutrition & agriculture · 2024
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Antitumor Potential ofAntioxidants (Basel, Switzerland) · 2021
    Article
  17. Iranian journal of basic medical sciences · 2021
    Article
  18. Review
  19. Review
  20. Terpenes/Terpenoids inMedical cannabis and cannabinoids · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Siyamak Ebrahimi NigjehInstitute of Bioscience, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia.
Swee Keong YeapChina-ASEAN College of Marine Sciences, Xiamen University Malaysia, Jalan Sunsuria, Bandar Sunsuria, Sepang 43900, Selangor, Malaysia.
Norshariza NordinFaculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia.
Heshu RahmanDepartment of Medical Laboratory Sciences and Technology, College of Health Sciences, Komar University of Science and Technology, Chaq Chaq Qularaese, Sarchinar District, Sulaimani 334, Iraq.
Rozita RosliInstitute of Bioscience, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia. rozita@upm.edu.my.
Universiti Putra Malaysia · MYKomar University of Science and Technology · IQXiamen University Malaysia · MY

Funding

MAKNA 6300123
6 · The paper itself

Abstract

Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death among females globally. The tumorigenic activities of cancer cells such as aldehyde dehydrogenase (ALDH) activity and differentiation have contributed to relapse and eventual mortality in breast cancer. Thus, current drug discovery research is focused on targeting breast cancer cells with ALDH activity and their capacity to form secondary tumors. Citral (3,7-dimethyl-2,6-octadienal), from lemon grass (

Indexed as

Acyclic MonoterpenesAldehyde DehydrogenaseAnimalsAntineoplastic AgentsApoptosisBreast NeoplasmsCaspase 3Cell Line, TumorDisease Models, AnimalFemaleImmunohistochemistryMiceMice, Inbred BALB CXenograft Model Antitumor AssaysAcyclic MonoterpenesAldehyde DehydrogenaseAntineoplastic AgentsCaspase 3citralALDHbreast cancercitraltumorigenicity

Identifiers

PMID31492037
PMCPMC6767168
OpenAlexW2972296916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.